IIM
ASTH icon

Illumine Investment Management’s Astrana Health ASTH Stock Holding History

Illumine Investment Management’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18,255
Closed -$566K – 95
2025
Q1 		$566K Buy
+18,255
New +$608K 0.46% 64

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Illumine Investment Management's ASTH Position: Q2 2025 in Review

Illumine Investment Management sold out of Astrana Health (ASTH) in Q2 2025, closing a stake of 18,255 shares — an estimated $566K sold.

Illumine Investment Management first reported a position in ASTH in Q1 2025 and held it in 1 quarter. The position peaked at $566K in Q1 2025. 162 funds tracked by Wall St. Rank hold ASTH as of Q2 2025.

  • Illumine Investment Management reported no remaining Astrana Health position as of Q2 2025 after selling out during the quarter.
  • Illumine Investment Management sold 18,255 Astrana Health shares in Q2 2025, an estimated $566K.
  • Illumine Investment Management first reported a position in Astrana Health in Q1 2025 and held it in 1 quarter.
  • Illumine Investment Management's Astrana Health position peaked at $566K in Q1 2025.
  • 162 funds tracked by Wall St. Rank held Astrana Health as of Q2 2025.

Based on Illumine Investment Management's 13F filing for Q2 2025, filed 7 Aug 2025.